Need Help?

scRNA-seq, scTCR-seq and scBCR-seq of 21 individuals post Covid'19 vaccination.

This data includes scRNA-seq, scTCR-seq and scBCR-seq of 21 individuals post Covid'19 vaccination. Individuals range from the ages 52 to 75. Samples were genotype multiplexed in an overlapping mixture design, pooled, and sequenced on 16 lanes (10X, 5' GEM).

Request Access

DATA ACCESS AGREEMENT for data generated at the Gupta Lab, University of Cambridge.

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom Professor Ravindra K. Gupta grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: Professor Ravindra K. Gupta and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. XXXXX: Your Institution details here 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify Professor Ravindra K. Gupta within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify Professor Ravindra K. Gupta prior to any significant changes to the protocol for the Project. 14. The User Institution will notify Professor Ravindra K. Gupta as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. Professor Ravindra K. Gupta may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than Professor Ravindra K. Gupta. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of England and Wales and shall be subject to the exclusive jurisdiction of the English courts.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001007385 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00008180665 fastq.gz 1.6 GB
EGAF00008180666 fastq.gz 1.7 GB
EGAF00008180667 fastq.gz 2.2 GB
EGAF00008180668 fastq.gz 2.4 GB
EGAF00008180669 fastq.gz 2.4 GB
EGAF00008180670 fastq.gz 2.5 GB
EGAF00008180671 fastq.gz 2.3 GB
EGAF00008180672 fastq.gz 2.5 GB
EGAF00008180673 fastq.gz 2.4 GB
EGAF00008180674 fastq.gz 2.6 GB
EGAF00008180675 fastq.gz 2.1 GB
EGAF00008180676 fastq.gz 2.3 GB
EGAF00008180677 fastq.gz 1.8 GB
EGAF00008180678 fastq.gz 1.9 GB
EGAF00008180679 fastq.gz 1.8 GB
EGAF00008180680 fastq.gz 1.9 GB
EGAF00008180681 fastq.gz 1.8 GB
EGAF00008180682 fastq.gz 1.9 GB
EGAF00008180683 fastq.gz 579.3 MB
EGAF00008180684 fastq.gz 617.4 MB
EGAF00008180685 fastq.gz 1.8 GB
EGAF00008180686 fastq.gz 1.9 GB
EGAF00008180687 fastq.gz 2.1 GB
EGAF00008180688 fastq.gz 2.3 GB
EGAF00008180689 fastq.gz 1.9 GB
EGAF00008180690 fastq.gz 2.0 GB
EGAF00008180691 fastq.gz 1.9 GB
EGAF00008180692 fastq.gz 2.0 GB
EGAF00008180693 fastq.gz 1.6 GB
EGAF00008180694 fastq.gz 1.7 GB
EGAF00008180695 fastq.gz 3.0 GB
EGAF00008180696 fastq.gz 3.2 GB
EGAF00008180697 fastq.gz 27.7 GB
EGAF00008180698 fastq.gz 29.2 GB
EGAF00008180699 fastq.gz 26.8 GB
EGAF00008180700 fastq.gz 28.3 GB
EGAF00008180701 fastq.gz 25.5 GB
EGAF00008180702 fastq.gz 26.7 GB
EGAF00008180703 fastq.gz 24.9 GB
EGAF00008180704 fastq.gz 25.9 GB
EGAF00008180705 fastq.gz 27.7 GB
EGAF00008180706 fastq.gz 28.6 GB
EGAF00008180707 fastq.gz 18.5 GB
EGAF00008180708 fastq.gz 19.5 GB
EGAF00008180709 fastq.gz 27.6 GB
EGAF00008180710 fastq.gz 29.5 GB
EGAF00008180711 fastq.gz 17.7 GB
EGAF00008180712 fastq.gz 18.6 GB
EGAF00008180713 fastq.gz 21.3 GB
EGAF00008180714 fastq.gz 22.1 GB
EGAF00008180715 fastq.gz 13.9 GB
EGAF00008180716 fastq.gz 14.6 GB
EGAF00008180717 fastq.gz 19.5 GB
EGAF00008180718 fastq.gz 20.7 GB
EGAF00008180719 fastq.gz 20.9 GB
EGAF00008180720 fastq.gz 22.1 GB
EGAF00008180721 fastq.gz 28.9 GB
EGAF00008180722 fastq.gz 30.0 GB
EGAF00008180723 fastq.gz 19.9 GB
EGAF00008180724 fastq.gz 20.7 GB
EGAF00008180725 fastq.gz 26.3 GB
EGAF00008180726 fastq.gz 27.2 GB
EGAF00008180727 fastq.gz 35.8 GB
EGAF00008180728 fastq.gz 38.5 GB
EGAF00008180729 fastq.gz 1.9 GB
EGAF00008180730 fastq.gz 1.9 GB
EGAF00008180731 fastq.gz 2.0 GB
EGAF00008180732 fastq.gz 2.0 GB
EGAF00008180733 fastq.gz 1.9 GB
EGAF00008180734 fastq.gz 2.0 GB
EGAF00008180735 fastq.gz 1.5 GB
EGAF00008180736 fastq.gz 1.6 GB
EGAF00008180737 fastq.gz 1.9 GB
EGAF00008180738 fastq.gz 2.0 GB
EGAF00008180739 fastq.gz 1.9 GB
EGAF00008180740 fastq.gz 2.0 GB
EGAF00008180741 fastq.gz 1.9 GB
EGAF00008180742 fastq.gz 2.0 GB
EGAF00008180743 fastq.gz 1.7 GB
EGAF00008180744 fastq.gz 1.7 GB
EGAF00008180745 fastq.gz 1.8 GB
EGAF00008180746 fastq.gz 1.9 GB
EGAF00008180747 fastq.gz 1.7 GB
EGAF00008180748 fastq.gz 1.7 GB
EGAF00008180749 fastq.gz 1.3 GB
EGAF00008180750 fastq.gz 1.3 GB
EGAF00008180751 fastq.gz 1.8 GB
EGAF00008180752 fastq.gz 1.9 GB
EGAF00008180753 fastq.gz 1.7 GB
EGAF00008180754 fastq.gz 1.8 GB
EGAF00008180755 fastq.gz 2.9 GB
EGAF00008180756 fastq.gz 3.0 GB
EGAF00008180757 fastq.gz 1.2 GB
EGAF00008180758 fastq.gz 1.2 GB
EGAF00008180759 fastq.gz 1.6 GB
EGAF00008180760 fastq.gz 1.6 GB
96 Files (908.7 GB)